Navigation Links
New Oral Biologics Delivery Company, Entrega, Announces Strategic Partnership with Pharma
Date:1/10/2011

BOSTON, Jan. 10, 2011 /PRNewswire/ -- Entrega, Inc., a new company developing oral drug delivery technologies, today announced its formation by Enlight Biosciences, a Boston-based company established in partnership with a group of leading global pharmaceutical companies. As part of its initial development program, Entrega will use its unique spatially-directed proprietary drug delivery platform to create orally bioavailable formulations of several of the biologic drugs of Enlight's pharmaceutical industry partners, for which Entrega will receive undisclosed payments including upfront and research milestone payments.  Entrega will remain independent and retain all rights to the platform technology.

(Logo: http://photos.prnewswire.com/prnh/20110110/NE26979LOGO)

"Entrega's technology could have a major impact on medicine by enabling the oral delivery of drugs that would typically require injection," said Dr. Robert Langer, David H. Koch Institute Professor at MIT, Entrega SAB Chair. "The relationship with pharma will support Entrega's unique technology and strengthen the platform significantly."  

Biologic drugs (biologics), such as insulin and antibodies, represent over $120 Billion in annual revenues and address major medical needs in areas such as cancer and inflammatory disease.  However, most biologics need to be delivered by injection, which leads to challenges in compliance and effectiveness. The ability to deliver biologics orally would address a significant unmet need for patients around the world. Entrega's proprietary drug delivery technology offers an innovative approach to deliver a wide variety of peptides and proteins via oral administration.

Entrega, Inc. was formed by Enlight Biosciences, a unique entrepreneurial collaboration to discover and develop platform technologies that will have a transformational impact on drug discovery and devel
'/>"/>

SOURCE Entrega, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
2. Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
3. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
4. Savient Submits Biologics License Application (BLA) for pegloticase
5. DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter
6. Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
7. Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
8. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
9. Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences
10. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
11. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Many factors impact tissues targeting such as ... at the blood-tissue barrier. Even when tissue disposition is ... the tissue rather than the total tissue concentration. , ... to guide lead optimization, predict in vivo activity in ... may impact the likely human clinical dose. , In ...
(Date:5/24/2013)... WI (PRWEB) May 24, 2013 ... the discovery and development of calcium-binding proteins to ... of safety assessment study of apoaequorin ... international journal published for the British Industrial Biological ... study was to investigate potential adverse effects, if ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... 23, 2013 Graphite Metallizing Corporation ... bushings mounted in stainless steel pillow blocks. This ... GRAPHALLOY with the application and installation versatility of ... Blocks work exceptionally well when submerged in ... liquids such as acids, alkalies, hydrocarbons, black liquor, ...
Breaking Biology Technology:DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3
... Nov. 8 Kosan Biosciences,Incorporated (Nasdaq: KOSN ) today ... 30, 2007. Net loss for the quarter and nine ... or $0.26 per share and $0.46 per share,compared to a ... and,$0.76 per share, in the same periods last year. ...
... and the Aflac Cancer Center for ... against pediatric cancer., COLUMBUS, Ga., Nov. 8 Last ... and the Aflac Cancer Center and,Blood Disorders Service at Children,s ... Corporate Citizenship Award. During a,prestigious ceremony hosted by television personality, ...
... Inc. (Nasdaq: MGRM ) announced today that William ... corporate overview at the Piper,Jaffray 19th Annual Healthcare Conference ... at the Pierre Hotel in New York. To ... log on to http://www.monogrambio.com and go to ...
Cached Biology Technology:Kosan Announces Third Quarter 2007 Financial Results 2Kosan Announces Third Quarter 2007 Financial Results 3Kosan Announces Third Quarter 2007 Financial Results 4Kosan Announces Third Quarter 2007 Financial Results 5Kosan Announces Third Quarter 2007 Financial Results 6Kosan Announces Third Quarter 2007 Financial Results 7Aflac Honored with Corporate Citizenship Award 2Aflac Honored with Corporate Citizenship Award 3Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference 2
(Date:5/22/2013)... have developed a novel technique that can detect molecular ... that is one of the most important, though time-consuming, ... a paper in Nature , post-doctoral researcher David ... Schnell of the Center for Free-Electron Laser Science (CFEL) ... finely-tuned microwave fields to identify molecular variants apart, and ...
(Date:5/22/2013)... Bethesda, Md. (May 22, 2013)The omega 3 fatty acids ... against cardiovascular diseaseso much so that the American Heart ... fish a week, particularly fatty varieties rich in omega ... remains a mystery. In a new study, scientists led ... light on this phenomenon by providing evidence that fish ...
(Date:5/22/2013)... The discovery of potential environmental and human health ... batteries each year has led scientists to recommend ... reuse of lithium-ion (Li-ion) battery materials. That,s the ... journal Environmental Science & Technology . , ... Li-ion batteries have become mainstays for powering everything ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3Fish oil may help the heart beat mental stress 2
... more than a breath freshener it could spot head ... Cancer Center. Their new study of a mouth rinse ... for screening those at high risk, including heavy smokers and ... at Johns Hopkins asked 211 head and neck cancer patients ...
... In the January 1st issue of G&D, Drs. Thomas ... into the degradation of mammalian histone,mRNA. Histone mRNA ... but the,mechanism by which this occurs has remained elusive, ... structure rather than the,canonical 3, poly(A) tail. Drs. ...
... -- A research team at Weill Cornell Medical College in ... crucial to the production of an immune system cytokine called ... important "missing link" in a biochemical pathway that,s long been ... to cancer and AIDS. "IL-10 production has to be ...
Cached Biology News:'Swish-and-spit' test accurate for cancer 22 genes are important key to regulating immune response 22 genes are important key to regulating immune response 3
With L-glutamine and potassium bicarbonate. Sterile, Insect cell culture tested...
Matrix for protein MALDI-MS...
A set of five proteins which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
... of Grace's medium were developed in several ... Many of these modifications were developed by ... cells derived from the cabbage looper,Tricoplusia ni. ... TNM-FH. The medium when properly supplemented has ...
Biology Products: